Preclinical In-vivo Imaging Market by Modality (optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems), by Reagent (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Preclinical In-vivo Imaging Market by Modality (optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems), by Reagent (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 582 | Pages: 175 | September 2016 | Region: Global


The Global Preclinical in-vivo imaging market has been estimated at USD 745 Million in 2016 and is projected to reach USD 1004.05 Million by 2021, at a CAGR of 6.15% during the forecast period from 2016 to 2021.  Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Imaging modalities that are non-invasive and in-vivo is important to study animal models longitudinally. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. Pre-clinical in-vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the global over the past decade. 

Globally, factors such as technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool, are fueling the demand of preclinical imaging systems and reagents. Declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global preclinical imaging market.

Global market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the global preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the global preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.

Geographically, Global market for Preclinical In-vivo Imaging is segmented into North America, Asia Pacific, Latin America, Europe, and Africa & Middle-East. North America holds the largest share of the global preclinical imaging market, followed by Europe. Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for development of pharmaceutical industry are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.

Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America          

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  2. Global Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  3. Global Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  4. Global Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  5. Global Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  6. Global Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  7. Global Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  8. Global Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  9. Global Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  10. Global Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  11. Global Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  12. Global Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  13. Global Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  14. Global Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  15. Global Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  16. Global Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  17. Global Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  18. Global Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  19. Global Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  20. Global Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  21. Global Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  22. Global Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  23. Global Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  24. Global Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  25. Global Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  26. North America Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  27. North America Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  28. North America Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  29. North America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  30. North America Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  31. North America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  32. North America Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  33. North America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  34. North America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  35. North America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  36. North America Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  37. North America Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  38. North America Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  39. North America Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  40. North America Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  41. North America Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  42. North America Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  43. North America Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  44. North America Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  45. North America Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  46. North America Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  47. North America Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  48. North America Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  49. North America Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  50. North America Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  51. United States Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  52. United States Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  53. United States Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  54. United States Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  55. United States Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  56. United States Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  57. Canada Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  58. Canada Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  59. Canada Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  60. Canada Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  61. Canada Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  62. Canada Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  63. Europe Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  64. Europe Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  65. Europe Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  66. Europe Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  67. Europe Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  68. Europe Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  69. Europe Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  70. Europe Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  71. Europe Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  72. Europe Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  73. Europe Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  74. Europe Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  75. Europe Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  76. Europe Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  77. Europe Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  78. Europe Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  79. Europe Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  80. Europe Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  81. Europe Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  82. Europe Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  83. Europe Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  84. Europe Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  85. Europe Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  86. Europe Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  87. Europe Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  88. U.K Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  89. U.K Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  90. U.K Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  91. U.K Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  92. U.K Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  93. U.K Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  94. Spain Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  95. Spain Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  96. Spain Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  97. Spain Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  98. Spain Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  99. Spain Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  100. Germany Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  101. Germany Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  102. Germany Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  103. Germany Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  104. Germany Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  105. Germany Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  106. Italy Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  107. Italy Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  108. Italy Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  109. Italy Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  110. Italy Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  111. Italy Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  112. France Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  113. France Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  114. France Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  115. France Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  116. France Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  117. France Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  118. Asia-Pacific Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  119. Asia-Pacific Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  120. Asia-Pacific Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  121. Asia-Pacific Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  122. Asia-Pacific Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  123. Asia-Pacific Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  124. Asia-Pacific Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  125. Asia-Pacific Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  126. Asia-Pacific Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  127. Asia-Pacific Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  128. Asia-Pacific Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  129. Asia-Pacific Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  130. Asia-Pacific Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  131. Asia-Pacific Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  132. Asia-Pacific Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  133. Asia-Pacific Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  134. Asia-Pacific Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  135. Asia-Pacific Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  136. Asia-Pacific Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  137. Asia-Pacific Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  138. Asia-Pacific Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  139. Asia-Pacific Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  140. Asia-Pacific Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  141. Asia-Pacific Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  142. Asia-Pacific Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  143. China Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  144. China Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  145. China Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  146. China Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  147. China Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  148. China Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  149. India Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  150. India Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  151. India Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  152. India Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  153. India Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  154. India Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  155. Japan Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  156. Japan Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  157. Japan Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  158. Japan Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  159. Japan Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  160. Japan Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  161. South Korea Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  162. South Korea Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  163. South Korea Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  164. South Korea Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  165. South Korea Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  166. South Korea Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  167. Australia Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  168. Australia Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  169. Australia Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  170. Australia Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  171. Australia Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  172. Australia Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  173. Latin America Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  174. Latin America Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  175. Latin America Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  176. Latin America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  177. Latin America Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  178. Latin America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  179. Latin America Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  180. Latin America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  181. Latin America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  182. Latin America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  183. Latin America Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  184. Latin America Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  185. Latin America Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  186. Latin America Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  187. Latin America Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  188. Latin America Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  189. Latin America Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  190. Latin America Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  191. Latin America Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  192. Latin America Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  193. Latin America Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  194. Latin America Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  195. Latin America Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  196. Latin America Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  197. Latin America Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  198. Brazil Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  199. Brazil Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  200. Brazil Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  201. Brazil Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  202. Brazil Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  203. Brazil Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  204. Argentina Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  205. Argentina Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  206. Argentina Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  207. Argentina Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  208. Argentina Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  209. Argentina Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  210. Mexico Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  211. Mexico Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  212. Mexico Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  213. Mexico Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  214. Mexico Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  215. Mexico Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  216. Middle East & Africa Preclinical in-vivo imaging Market By Region, From 2016-2021 (USD Million)
  217. Middle East & Africa Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  218. Middle East & Africa Preclinical Optical imaging Market By Region, From 2016-2021 (USD Million)
  219. Middle East & Africa Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  220. Middle East & Africa Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2021 (USD Million)
  221. Middle East & Africa Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2021 (USD Million)
  222. Middle East & Africa Preclinical Nuclear imaging Market By Region, From 2016-2021 (USD Million)
  223. Middle East & Africa Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2021 (USD Million)
  224. Middle East & Africa Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2021 (USD Million)
  225. Middle East & Africa Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2021 (USD Million)
  226. Middle East & Africa Preclinical Micro-MRI Market By Region, From 2016-2021 (USD Million)
  227. Middle East & Africa Preclinical Micro-CT Market By Region, From 2016-2021 (USD Million)
  228. Middle East & Africa Preclinical Micro-ultrasound Market By Region, From 2016-2021 (USD Million)
  229. Middle East & Africa Preclinical Photoacoustic Market By Region, From 2016-2021 (USD Million)
  230. Middle East & Africa Preclinical Magnetic particle imaging systems Market By Region, From 2016-2021 (USD Million)
  231. Middle East & Africa Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  232. Middle East & Africa Preclinical Optical imaging reagents Market By Region, From 2016-2021 (USD Million)
  233. Middle East & Africa Preclinical Bioluminescent reagents Market By Region, From 2016-2021 (USD Million)
  234. Middle East & Africa Preclinical Fluorescent imaging reagents Market By Region, From 2016-2021 (USD Million)
  235. Middle East & Africa Preclinical Nuclear imaging reagents Market By Region, From 2016-2021 (USD Million)
  236. Middle East & Africa Preclinical PET tracers Market By Region, From 2016-2021 (USD Million)
  237. Middle East & Africa Preclinical SPECT probes Market By Region, From 2016-2021 (USD Million)
  238. Middle East & Africa Preclinical MRI contrast agents Market By Region, From 2016-2021 (USD Million)
  239. Middle East & Africa Preclinical Ultrasound contrast agents Market By Region, From 2016-2021 (USD Million)
  240. Middle East & Africa Preclinical CT contrast agents Market By Region, From 2016-2021 (USD Million)
  241. Middle East Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  242. Middle East Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  243. Middle East Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  244. Middle East Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  245. Middle East Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  246. Middle East Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
  247. Africa Preclinical in-vivo imaging Market By Modality, From 2016-2021 (USD Million)
  248. Africa Preclinical Optical Imaging Market By Optical imaging, From 2016-2021 (USD Million)
  249. Africa Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2021 (USD Million)
  250. Africa Preclinical in-vivo imaging Market By Reagent, From 2016-2021 (USD Million)
  251. Africa Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2021 (USD Million)
  252. Africa Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2021 (USD Million)
Middle East And Africa Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridizat...
Latin America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Asia Pacific Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End ...
Europe Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (...
North America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospita...
Middle East And Africa RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray...
Latin America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
Asia Pacific RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNA...
Europe RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By...
North America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By Region...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.